Cyclosporine A induces kidney dysfunction by the alteration of molecular mediators involved in slit diaphragm regulation and matrix metalloproteins: the mitigating effect of curcumin

References

• Kahan BD. Cyclosporine. N Engl J Med. 1989;321(25):1725–1738.
   Google Scholar
• Buurman W,Daemen A J,Van der Linden, et al. Clinically used concentrations of cyclosporine A only partially inhibit interferon-gamma production by activated T lymphocytes. Transplantation proc.1987; 19(1pt2):1193
   Google Scholar
• Colombo MD, Perego R, Bellia G. Cyclosporine-associated nephrotoxicity. Open J Nephrol. 2013;3(3):168.
   Google Scholar
• Kim S,Song H,Hwang J et al. Cyclosporine nephrotoxicity: the mechanisms of cell injury by cyclosporine A in renal proximal tubular cells. Transplantation proc. 2000;32(7):1621–1622
   Google Scholar
• Kim HS, Choi S-I, Jeung E-B, et al. Cyclosporine A induces apoptotic and autophagic cell death in rat pituitary GH3 cells. PLoS One. 2014;9(10):e108981.
   Google Scholar
• Koh ES D-Pinitol alleviates cyclosporine A-induced renal tubulointerstitial fibrosis via activating Sirt1 and Nrf2 antioxidant pathways. Int J Mol Med. 2018;41(4):1826–1834.
   Google Scholar
• Yoon HE, Yang CW. Established and newly proposed mechanisms of chronic cyclosporine nephropathy. Korean J Intern Med. 2009;24(2):81.
   Google Scholar
• Lee J. Use of antioxidants to prevent cyclosporine a toxicity. Toxicol Res. 2010;26(3):163.
   Google Scholar
• Alrashedi MG, Ali AS, Ali SS, et al. Impact of thymoquinone on cyclosporine A pharmacokinetics and toxicity in rodents. J Pharm Pharmacol. 2018;70(10):1332–1339.
   Google Scholar
• Damiano S, Ciarcia R, Montagnaro S, et al. Prevention of nephrotoxicity induced by cyclosporine‐A: role of antioxidants. J Cell Biochem. 2015;116(3):364–369.
   Google Scholar
• Olukman M, can C, Coşkunsever D, et al. Urotensin receptor antagonist palosuran attenuates cyclosporine-a-induced nephrotoxicity in rats. Adv Clin Exp Med. 2019;28(10):1393–1401.
   Google Scholar
• Franceschini N, Alpers CE, Bennett WM, et al. Cyclosporine arteriolopathy: effects of drug withdrawal. Am J Kidney Dis. 1998;32(2):247–253.
   Google Scholar
• Cid TP Antioxidant nutrients protect against cyclosporine A nephrotoxicity. Toxicology. 2003;189(1–2):99–111.
   Google Scholar
• Mason J. The effect of cyclosporin on renal function. J Autoimmun. 1992;5:349–354.
   Google Scholar
• Young EW, Ellis CN, Messana JM, et al. A prospective study of renal structure and function in psoriasis patients treated with cyclosporin. Kidney Int. 1994;46(4):1216–1222.
   Google Scholar
• Chen S,Chen H, Liu Q,et al. Effect of simvastatin on the expression of nephrin, podocin, and vascular endothelial growth factor (VEGF) in podocytes of diabetic rat. Int J Clin Exp Med. 2015;8(10):18225–18234
   Google Scholar
• Dai Y, Gu L, Yuan W, et al. Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum–induced glomerulonephritis. Kidney Int. 2013;84(5):950–961.
   Google Scholar
• Huwiler A, Ren S, Holthöfer H, et al. Inflammatory cytokines upregulate nephrin expression in human embryonic kidney epithelial cells and podocytes. Biochem Biophys Res Commun. 2003;305(1):136–142.
   Google Scholar
• Schaefer L Nephrin expression is increased in anti-Thy1. 1-induced glomerulonephritis in rats. Biochem Biophys Res Commun. 2004;324(1):247–254.
   Google Scholar
• Antignac C. Genetic models: clues for understanding the pathogenesis of idiopathic nephrotic syndrome. J Clin Invest. 2002;109(4):447–449.
   Google Scholar
• He -F-F, Chen S, Su H, et al. Actin-associated proteins in the pathogenesis of podocyte injury. Curr Genomics. 2013;14(7):477–484.
   Google Scholar
• Huber TB, Köttgen M, Schilling B, et al. Interaction with podocin facilitates nephrin signaling. J Biol Chem. 2001;276(45):41543–41546.
   Google Scholar
• Wachsstock DH, Schwartz W, Pollard TD. Affinity of alpha-actinin for actin determines the structure and mechanical properties of actin filament gels. Biophys J. 1993;65(1):205–214.
   Google Scholar
• Wang G, Lai FM-M, Lai K-B, et al. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy. Nephron Clin Pract. 2007;106(4):c169–c179.
   Google Scholar
• Zhao X, Khurana S, Charkraborty S, et al. α actinin 4 (ACTN4) regulates glucocorticoid receptor-mediated transactivation and transrepression in podocytes. J Biol Chem. 2017;292(5):1637–1647.
   Google Scholar
• Tan RJ, Liu Y. Matrix metalloproteinases in kidney homeostasis and diseases. Am J Physiol Renal Physiol. 2012;302(11):F1351–F1361.
   Google Scholar
• Gupta SC, Patchva S, Koh W, et al. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012;39(3):283–299.
   Google Scholar
• Fujisawa S, Atsumi T., Ishihara M. Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Res. 2004;24(2B):563–569.
   Google Scholar
• Calabrese V, Bates TE, Mancuso C. Curcumin and the cellular stress response in free radical-related diseases. Mol Nutr Food Res. 2008;52(9):1062–1073.
   Google Scholar
• Huang J, Yao X, Weng G. et al. Protective effect of curcumin against cyclosporine Ainduced rat nephrotoxicity. Mol Med Rep. 2018;17(4):6038–6044.
   Google Scholar
• Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. The molecular targets and therapeutic uses of curcumin in health and disease. Adv Exp Med Biol 2007; 595105–125
   Google Scholar
• Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41(4):467–470.
   Google Scholar
• Hewedy WA, Mostafa DK. Nebivolol suppresses asymmetric dimethylarginine and attenuates cyclosporine-induced nephrotoxicity and endothelial dysfunction in rats. Pharmacol Rep. 2016;68(6):1319–1325.
   Google Scholar
• Lin C-X, Li Y, Liang S, et al. Metformin attenuates cyclosporine A-induced renal fibrosis in rats. Transplantation. 2019;103(10): e285-e296. doi:10.1097/TP.0000000000002864.
   Google Scholar
• Wu J-B, Ye S-F, Liang C-L, et al. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury. J Ethnopharmacol. 2014;151(3):1124–1132.
   Google Scholar
• Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75(6):652–660.
   Google Scholar
• Cruzado LB, Pérez González E, Martínez Martos Z, et al. Serum cystatin C levels in preterm newborns in our setting: correlation with serum creatinine and preterm pathologies. Nefrología (English Edition). 2015;35(3):296–303.
   Google Scholar
• Purde M-T, Nock S, Risch L, et al. The cystatin C/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors. Transl Res. e2 2016;169: 80–90.
   Google Scholar
• Grubb A, Lindström V, Jonsson M, et al. Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: ‘Shrunken pore syndrome’. Scand J Clin Lab Invest. 2015;75(4):333–340.
   Google Scholar
• Lund U, Rippe A, Venturoli D, et al. Glomerular filtration rate dependence of sieving of albumin and some neutral proteins in rat kidneys. Am J Physiol Renal Physiol. 2003;284(6):F1226–F1234.
   Google Scholar
• Coward RJM, Foster RR, Patton D, et al. Nephrotic plasma alters slit diaphragm–dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol. 2005;16(3):629–637.
   Google Scholar
• Kerjaschki D. Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest. 2001;108(11):1583–1587.
   Google Scholar
• Benzing T. Signaling at the slit diaphragm. J Am Soc Nephrol. 2004;15(6):1382–1391.
   Google Scholar
• Huber TB, Simons M, Hartleben B, et al. Molecular basis of the functional podocin–nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet. 2003;12(24):3397–3405.
   Google Scholar
• Roselli S, Heidet L, Sich M, et al. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol. 2004;24(2):550–560.
   Google Scholar
• Kim JM CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Sci. 2003;300(5623):1298–1300.
   Google Scholar
• Kaplan JM, H Kim S, North KN, et al. Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet. 2000;24(3):251.
   Google Scholar
• Kos CH, Le TC, Sinha S, et al. Mice deficient in α-actinin-4 have severe glomerular disease. J Clin Invest. 2003;111(11):1683–1690.
   Google Scholar
• Michaud J-L, Lemieux LI, Dubé M., et al. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant α-actinin-4. J Am Soc Nephrol. 2003;14(5):1200–1211.
   Google Scholar
• Liu C, Zhu P, Fujino M, et al. 5-aminolaevulinic acid (ALA), enhances heme oxygenase (HO)-1 expression and attenuates tubulointerstitial fibrosis and renal apoptosis in chronic cyclosporine nephropathy. Biochem Biophys Res Commun. 2019;508(2):583–589.
   Google Scholar
• Ren S, Xin C, Beck K-F, et al. PPARα activation upregulates nephrin expression in human embryonic kidney epithelial cells and podocytes by a dual mechanism. Biochem Biophys Res Commun. 2005;338(4):1818–1824.
   Google Scholar
• El-Bassossy HM, Eid BG. Cyclosporine A exhibits gender-specific nephrotoxicity in rats: effect on renal tissue inflammation. Biochem Biophys Res Commun. 2018;495(1):468–472.
   Google Scholar
• Narula S, Tandon C, Tandon S. Role of matrix metalloproteinases in degenerative kidney disorders. Curr Med Chem. 2018;25(15):1805–1816.
   Google Scholar
• Liu M, Wang G, et al. Signalling pathways involved in hypoxia‐induced renal fibrosis. J Cell Mol Med. 2017;21(7):1248–1259.
   Google Scholar
• Chen W-C, Lin -H-H, Tang M-J. Regulation of proximal tubular cell differentiation and proliferation in primary culture by matrix stiffness and ECM components. Am J Physiol-Renal Physiol. 2014;307(6):F695–F707.
   Google Scholar
• Han SY, Jee YH, Han KH, et al. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy. Nephrol Dialysis Transplantation. 2006;21(9):2406–2416.
   Google Scholar
• Hernandez-Resendiz S, Correa F, García-Niño WR, et al. Cardioprotection by curcumin post-treatment in rats with established chronic kidney disease. Cardiovasc Drugs Ther. 2015;29(2):111–120.
   Google Scholar
• Chauhan PS, Dash D, Singh R. Intranasal curcumin inhibits pulmonary fibrosis by modulating matrix metalloproteinase-9 (MMP-9) in ovalbumin-induced chronic asthma. Inflammation. 2017;40(1):248–258.
   Google Scholar
• Ma J, Ma SY, Ding CH. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor beta1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinase 1. Chin J Integr Med. 2017;23(5):362–369.
   Google Scholar